SCHEMBL4350031

SCHEMBL4350031

Cc1ccc(/C=C2\SC(N3CCN(c4ccccc4F)CC3)=NC2=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.69
RAB9A P51151 3/20 0.67
ALDH1A1 P00352 4/20 0.58
DCTPP1 Q9H773 1/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
LMNA P02545 1/20 0.56
HPGD P15428 1/20 0.56
NPC1 O15118 4/20 0.56
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
GRIN1 Q05586 3/20 0.54
GRIN2B Q13224 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MAPK1 P28482 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
HTT P42858 1/20 0.53
ENPP2 Q13822 1/20 0.53
ALOX5 P09917 1/20 0.52
IDE P14735 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350035 1.00 MAPT (0.69) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4364883 0.88 HTT (0.71) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4352217 0.88 ALDH1A1 (0.71) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4352214 0.88 ALDH1A1 (0.71) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4364886 0.88 HTT (0.71) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4352779 0.87 MAPT (0.56) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4352782 0.87 MAPT (0.56) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4350565 0.84 ALDH1A1 (0.53) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4350559 0.84 ALDH1A1 (0.53) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2
SCHEMBL4357485 0.84 DCTPP1 (0.78) MAPTRAB9AALDH1A1DCTPP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 MAPT 1470/4885RAB9A 3151/4885ALDH1A1 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.